
    
      This study will be designed as an open randomized effectiveness study assessing the
      parasitological and clinical cure rates and adherence to oral quinine monotherapy in
      comparison to artemether-Lumefantrine. We will also describe some of the adverse events to
      the two drugs.The measurements will include age, sex, weight, hemoglobin levels on days 0, 7,
      14 and 28, parasite density on days 0, 7, 14 and 28 and clinical examination findings.
      Adverse events will also be documented
    
  